Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Petra Kristel"'
Autor:
Petra ter Brugge, Sarah C. Moser, Ivan Bièche, Petra Kristel, Sabrina Ibadioune, Alexandre Eeckhoutte, Roebi de Bruijn, Eline van der Burg, Catrin Lutz, Stefano Annunziato, Julian de Ruiter, Julien Masliah Planchon, Sophie Vacher, Laura Courtois, Rania El-Botty, Ahmed Dahmani, Elodie Montaudon, Ludivine Morisset, Laura Sourd, Léa Huguet, Heloise Derrien, Fariba Nemati, Sophie Chateau-Joubert, Thibaut Larcher, Anne Salomon, Didier Decaudin, Fabien Reyal, Florence Coussy, Tatiana Popova, Jelle Wesseling, Marc-Henri Stern, Jos Jonkers, Elisabetta Marangoni
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Homologous recombination deficiency is linked with platinum-based chemotherapy response in triple-negative breast cancer (TNBC) but methods to clinically identify these patients are lacking. Here, using patient-derived xenografts of TNBC the authors
Externí odkaz:
https://doaj.org/article/45c67b1c1e0a4a2998d04e87b0b265a7
Autor:
Marlous Hoogstraat, Esther H. Lips, Isabel Mayayo-Peralta, Lennart Mulder, Petra Kristel, Ingrid van der Heijden, Stefano Annunziato, Maartje van Seijen, Petra M. Nederlof, Gabe S. Sonke, Wilbert Zwart, Jelle Wesseling, Lodewyk F. A. Wessels
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract When locally advanced breast cancer is treated with neoadjuvant chemotherapy, the recurrence risk is significantly higher if no complete pathologic response is achieved. Identification of the underlying resistance mechanisms is essential to
Externí odkaz:
https://doaj.org/article/2615d770ea91484288e3fc2c9c92bdc1
Autor:
Marc J. van de Vijver, Harry Bartelink, Hans Peterse, Annuska Glas, Petra Kristel, Hans Halfwerk, Bas Kreike
http://microarrays.nki.nl/ from Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0bc2cc1dcc9ee0c136f352e32546caa
https://doi.org/10.1158/1078-0432.22441827.v1
https://doi.org/10.1158/1078-0432.22441827.v1
Autor:
Marc J. van de Vijver, Harry Bartelink, Hans Peterse, Annuska Glas, Petra Kristel, Hans Halfwerk, Bas Kreike
Purpose: Several risk factors for local recurrence of breast cancer after breast-conserving therapy (BCT) have been identified. The identification of additional risk factors would be very useful in guiding optimal therapy and also in improving unders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31385431aeec97db4261f98c94d730e2
https://doi.org/10.1158/1078-0432.c.6518733
https://doi.org/10.1158/1078-0432.c.6518733
Autor:
Marc J. van de Vijver, Lodewyk F.A. Wessels, Marcel J.T. Reinders, Petra M. Nederlof, Christiaan Klijn, Simon A. Joosse, Erik van Beers, Petra Kristel, Hans Halfwerk, Dimitry S.A. Nuyten, Carmen Lai, Hugo M. Horlings
Purpose: Several prognostic gene expression profiles have been identified in breast cancer. In spite of this progress in prognostic classification, the underlying mechanisms that drive these gene expression patterns remain unknown. Specific genomic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47773a6361ab83d49569dbadfa732758
https://doi.org/10.1158/1078-0432.c.6517936.v1
https://doi.org/10.1158/1078-0432.c.6517936.v1
Autor:
Marc J. van de Vijver, Harry Bartelink, Hans Peterse, Annuska Glas, Petra Kristel, Hans Halfwerk, Bas Kreike
Supplementary Data from Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d0243eacb6b1494ba528c76f0d91a89
https://doi.org/10.1158/1078-0432.22441830
https://doi.org/10.1158/1078-0432.22441830
Autor:
Marc J. van de Vijver, Lodewyk F.A. Wessels, Marcel J.T. Reinders, Petra M. Nederlof, Christiaan Klijn, Simon A. Joosse, Erik van Beers, Petra Kristel, Hans Halfwerk, Dimitry S.A. Nuyten, Carmen Lai, Hugo M. Horlings
Supplementary Table S2 from Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5047587bbb65333e87ba1edfdf9a9c9a
https://doi.org/10.1158/1078-0432.22440640.v1
https://doi.org/10.1158/1078-0432.22440640.v1
Autor:
Kaile Wang, Tapsi Kumar, Junke wang, Darlan Minussi, Emi Sei, Jianzhuo li, Tuan Tran, Aatish Thennavan, Min Hu, Anna Casasent, Zhenna Xiao, Shanshan Bai, Yuehui Zhao, Amado Zurita, Ana Aparicio, Brian Chapin, Jie ye, Jianjun Zhang, Don Gibbons, Andrew Futreal, Lorraine King, Jeffrey Marks, E. Shelley Hwang, Vandna Shah, Ellinor Sawyer, Petra Kristel, Jelle Wesseling, Esther H. Lips, Nicholas Navin
Publikováno v:
Cancer Research. 83:125-125
Ductal carcinoma in situ (DCIS) is a common precursor of invasive breast cancer (IBC), yet the genomic progression to recurrent disease remains poorly understood. A main contributor to this gap in knowledge arises from technical challenges with genom
Autor:
Stefan J. Hutten, Roebi de Bruijn, Catrin Lutz, Madelon Badoux, Timo Eijkman, Xue Chao, Marta Ciwinska, Andrea Herencia-Ropero, Petra Kristel, Lennart Mulder, Joyce Sanders, Mathilde Almekinders, Alba Llop-Gueverra, Helen R. Davies, Fariba Behbod, Serena Nik-Zainal, Violeta Serra, Jacco van Rheenen, Esther H. Lips, Lodewyk F.A. Wessels, Jelle Wesseling, Colinda Scheele, Jos Jonkers
Publikováno v:
Cancer Prevention Research. 15:PR006-PR006
Ductal Carcinoma in Situ (DCIS) is a non-invasive non-obligate precursor of invasive breast cancer (IBC). DCIS is usually treated by surgery combined with radiotherapy, which can have a large impact on the life of patients. However, many of these DCI
Autor:
Hendrik Messal, Colinda Scheele, Esther Lips, Catrin Lutz, Stefan Hutten, Petra Kristel, Carmen Vlahu, Jos Jonkers, Jelle Wesseling, Jacco van Rheenen
Publikováno v:
Cancer Prevention Research. 15:IA012-IA012
The architecture of the human breast undergoes extensive remodeling throughout puberty, the menstrual cycle, pregnancy and involution with a risk of accumulating genetic alterations and tissue changes. Cells that have acquired mutations in driver gen